206 related articles for article (PubMed ID: 19717847)
21. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
[TBL] [Abstract][Full Text] [Related]
23. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
[TBL] [Abstract][Full Text] [Related]
25. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment.
Bleeker GB; Bax JJ; Steendijk P; Schalij MJ; van der Wall EE
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):213-9. PubMed ID: 16568130
[TBL] [Abstract][Full Text] [Related]
27. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy.
Chung ES; Katra RP; Ghio S; Bax J; Gerritse B; Hilpisch K; Peterson BJ; Feldman DS; Abraham WT
Eur J Heart Fail; 2010 Jun; 12(6):581-7. PubMed ID: 20150328
[TBL] [Abstract][Full Text] [Related]
28. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.
Reynolds MR; Joventino LP; Josephson ME;
Pacing Clin Electrophysiol; 2004 Nov; 27(11):1513-8. PubMed ID: 15546306
[TBL] [Abstract][Full Text] [Related]
29. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.
Fröhlich G; Steffel J; Hürlimann D; Enseleit F; Lüscher TF; Ruschitzka F; Abraham WT; Holzmeister J
Eur Heart J; 2010 Jun; 31(12):1477-85. PubMed ID: 20233792
[TBL] [Abstract][Full Text] [Related]
30. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
[TBL] [Abstract][Full Text] [Related]
31. Cardiac resynchronization therapy in paediatric and congenital heart disease patients.
van der Hulst AE; Delgado V; Blom NA; van de Veire NR; Schalij MJ; Bax JJ; Roest AA; Holman ER
Eur Heart J; 2011 Sep; 32(18):2236-46. PubMed ID: 21450719
[TBL] [Abstract][Full Text] [Related]
32. Baseline characteristics of patients recruited into the CARE-HF study.
Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Klein W; Tavazzi L;
Eur J Heart Fail; 2005 Mar; 7(2):205-14. PubMed ID: 15701468
[TBL] [Abstract][Full Text] [Related]
33. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.
Mullens W; Grimm RA; Verga T; Dresing T; Starling RC; Wilkoff BL; Tang WH
J Am Coll Cardiol; 2009 Mar; 53(9):765-73. PubMed ID: 19245967
[TBL] [Abstract][Full Text] [Related]
34. Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy.
Porciani MC; Lilli A; Macioce R; Cappelli F; Demarchi G; Pappone A; Ricciardi G; Padeletti L
Eur Heart J; 2006 Aug; 27(15):1818-23. PubMed ID: 16818457
[TBL] [Abstract][Full Text] [Related]
35. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
36. Echocardiographic mapping of left ventricular resynchronization during cardiac resynchronization therapy procedures.
Chan NY; Choy CC; Cheung KC; Lau CL; Lo YK; Chu PS; Yuen HC; Lau ST; Choi YC
Chin Med J (Engl); 2010 Jul; 123(13):1645-51. PubMed ID: 20819622
[TBL] [Abstract][Full Text] [Related]
37. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.
Soliman OI; Geleijnse ML; Theuns DA; Nemes A; Vletter WB; van Dalen BM; Motawea AK; Jordaens LJ; ten Cate FJ
Am J Cardiol; 2008 Mar; 101(5):651-7. PubMed ID: 18308015
[TBL] [Abstract][Full Text] [Related]
38. Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy.
Hasselberg NE; Haugaa KH; Bernard A; Ribe MP; Kongsgaard E; Donal E; Edvardsen T
Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):343-50. PubMed ID: 26164406
[TBL] [Abstract][Full Text] [Related]
39. Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT.
van Bommel RJ; Gorcsan J; Chung ES; Abraham WT; Gjestvang FT; Leclercq C; Monaghan MJ; Nihoyannopoulos P; Peraldo C; Yu CM; Demas M; Gerritse B; Bax JJ
Heart; 2010 Jul; 96(14):1107-13. PubMed ID: 20610457
[TBL] [Abstract][Full Text] [Related]
40. Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels.
Hessel MH; Bleeker GB; Bax JJ; Henneman MM; den Adel B; Klok M; Schalij MJ; Atsma DE; van der Laarse A
Eur J Heart Fail; 2007 Oct; 9(10):1058-63. PubMed ID: 17728181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
